Health Discovery Corporation Introducing The World's First Mobile Phone App For Melanoma And Other Skin Cancers Using SVM-based Image Analysis Techniques
Health Discovery Corporation (OTCBB: HDVY) announced today that the Company is nearing completion in the development of a melanoma/skin cancer mobile phone application (App) which will enable customers to take a picture of a mole, lesion or birthmark on their bodies using their mobile phones, send the image to Health Discovery Corporation, and immediately receive back on their mobile phone a risk assessment for melanoma and other skin cancers. This first-ever melanoma/skin cancer mobile phone App using the Company’s patented and pioneering Support Vector Machine technology will employ sophisticated image analysis techniques using patent protected algorithms for evaluating moles, lesions and birthmarks. Health Discovery Corporation has applied for further patent protection for this latest application of its technology.
Today over 3 billion people or 47% of the world’s population use mobile phones, according to a recent report. By 2014, mobile phone penetration as a percentage of population is expected to reach 53% or 3.5 billion people.
Moles are growths on the skin. These growths occur when cells in the skin, called melanocytes grow in a cluster with tissue surrounding them. Moles are very common. Most people have between 10 and 40 moles. About one out of every ten people has at least one unusual (or atypical) mole that looks different from an ordinary mole. The medical term for these unusual moles is dysplastic nevi. Doctors believe that dysplastic nevi are more likely than ordinary moles to develop into a type of skin cancer called melanoma. Because of this, it is recommended that moles should be checked regularly.
Melanoma accounts for about 5% of skin cancer cases and a majority of skin cancer deaths. Melanoma is the fifth most common cancer among men and the sixth most common cancer in women. If Melanoma is found early before it has spread, the five-year relative survival rate is 99% whereas the five year relative survival rate if the melanoma is advanced with distant metastasis is only 16%.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV